±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 249  |  »Ø¸´: 2
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

gcr791030

[½»Á÷] Òì±û·ÓÓë¸ÎÔàȱѪÔÙ¹à×¢ËðÉ˵ÄÏà¹ØÐÔÑо¿

ÕªÒª£ºÄ¿Ç°Ñо¿ÏÔʾ£¬Òì±û·Ó¶Ô¸ÎÔàȱѪÔÙ¹à×¢ËðÉ˾ßÓб£»¤×÷Óá£Ëü·¢»Ó±£»¤×÷ÓõĿÉÄÜ»úÖÆ£¬Ö÷Ҫͨ¹ýÒì±û·Ó¶ÔÑõ×ÔÓÉ»ù¡¢¸ÆÀë×ӵĵ÷½Ú¡¢Ï¸°ûÒò×Ó¡¢Ï¸°ûµòÍöºÍÏßÁ£ÌåµÈ¼¸·½ÃæµÄ×÷ÓÃÀ´ÊµÏÖ¡£
¹Ø¼ü´Ê£ºÒì±û·Ó£»¸ÎÔࣻȱѪÔÙ¹à×¢ËðÉË
ÖÐͼ·ÖÀàºÅ£ºR614.1
   È±ÑªÔÙ¹à×¢ËðÉËÊÇÒ»ÖØÒªµÄÁÙ´²ÎÊÌ⣮¿ÉÒÔÉæ¼°µ½ÁÙ´²¸÷¿Æ¡£´óÁ¿µÄÑо¿Ö¤Ã÷£¬ÒýÆðȱѪÔÙ¹à×¢ËðÉ˵ĻúÖÆÊÇ¶à·½ÃæµÄ£¬ÓÐÑõ×ÔÓÉ»ù²úÉúÔö¼Ó¡¢Ï¸°ûÄڸƳ¬ÔØ¡¢Ï¸°ûÒò×ӵIJÎÓë¡¢Kupferϸ°û(Kupfer cell£¬KC)¼¤»î¼°ÖÐÐÔÁ£Ï¸(polymorphonuclear leukocyte£¬PMN)µÄ¾Û¼¯µÈ¡£Òì±û·Ó×÷ΪһÖÖÐÂÐ͵ľ²ÂöÂé×í¼Á£¬ÆäÓÐ×ÅÆðЧ¿ì¡¢ËÕÐÑѸËÙ¡¢Æ½Îȸ±×÷ÓÃÉÙµÈÌØµã¡£ÏÖÒÑ֤ʵÓÐÁ¼ºÃµÄ¿¹Ñõ»¯ºÍÒÖÖÆÏ¸°ûÒò×ÓÊͷŵŦÄÜ£¬ÏÖ½«Òì±û·Ó¶ÔHIRI×÷ÓõÄ×îÐÂÑо¿½øÕ¹×ÛÊöÈçÏ¡£
l  Òì±û·ÓÓëÑõ×ÔÓÉ»ù
   ÔÚÉúÀíÇé¿öÏ£¬ÉíÌåÄÚ²»¶Ï²úÉúÑõ×ÔÓÉ»ù£¬¶øÓÖ²»¶Ï½«ÆäÇå³ýÒÔά³ÖÔÚÒ»¸ö¶¯Ì¬Æ½ºâ״̬¡£HIRI¹ý³ÌÖУ¬ÓÉÓÚ¸Îϸ°ûȱѪȱÑõ£¬ATP·Ö½â´úлÔö¼Ó£¬Æä·Ö½â²úÎï´Î»ÆàÑßÊÔÚȱѪ×éÖ¯ÄÚ´óÁ¿¶Ñ»ý£¬Í¬Ê±È±ÑõҲʹÄÚÔ´ÐÔ¿¹Ñõ»¯¼ÁÈ糬Ñõ»¯ÎïÆç»¯Ã¸(SOD)ʧ»î»òºÄ¾¡£¬¶øÈ±ÑªµÄ´Ì¼¤¼¤»îCa2+ÒÀÀµµ°°×ø´Ù½ø°ûÄÚÎÞº¦µÄ»ÆàÑßÊÍÑÇâø(XDH)ÏòÓк¦µÄ»ÆàÑßÊÑõ»¯Ã¸(XOD)ת»¯£¬ºóÕßÀûÓðûÄÚ·Ö×ÓÑõ²úÉú´óÁ¿µÄÑõ×ÔÓÉ»ù¡£´ËÍ⣬¼¤»îµÄKC¡¢ÖÐÐÔÁ£Ï¸°û¡¢ÍÌÊÉϸ°ûºÍµ¥ºËϸ°ûÊܵ½È±Ñõ´Ì¼¤ºóͨ¹ýϸ°ûĤÉÏ»¹Ô­ÐÍÑÌõ£°·ÏÙàÑßʶþºËÜÕËá(NADPH)Ñõ»¯Ã¸×÷ÓÃ+ÊÍ·Å´óÁ¿Ñõ×ÔÓÉ»ù¡£ÏßÁ£ÌåÒ²ÊÇÑõ×ÔÓÉ»ùµÄÖØÒªÀ´Ô´¡£Ñõ×ÔÓÉ»ù¶Ô¸Îϸ°ûËðÉË»úÖÆÖ÷ÒªÓУº¢Ù Ñõ×ÔÓÉ»ù¶Ôϸ°ûĤ˫²ãÁ×Ö¬½á¹¹ÖеÄÖØÒªÖ¬Àà½øÐÐÑõ»¯×÷Óã¬Éú³É¶àÖÖÖ¬ÖʹýÑõ»¯Î´Ó¶øÖ±½ÓËðÉËϸ°û£»¢Ú Ñõ×ÔÓÉ»ùÄÜÒýÆðѪС°å¡¢Á£Ï¸°ûÔÚ΢Ѫ¹ÜÖÐ𤸽¡¢¾Û¼¯£®Ôì³É΢Ѫ¹ÜÕϰ­£»¢ÛÑõ×ÔÓÉ»ù¿ÉÖ±½ÓÑõ»¯¸ÎʵÖÊϸ°ûºËÄÚDNAË«Á´½á¹¹£¬ÒýÆðDNAÍ»±ä¶øÔì³É¸ÎÔà½á¹¹ºÍ¹¦ÄܵÄËðÉË¡£               
    Òì±û·ÓÔÚ»¯Ñ§½á¹¹ÉÏÓëÄÚÔ´ÐÔ¿¹Ñõ»¯¼ÁάÉúËØEºÍÒÑÖªµÄ¿¹Ñõ»¯¼Á¶¡»¯ôÇ»ù¼×±½Ê®·ÖÏàËÆ£¬Æä¿¹Ñõ»¯×÷ÓõĽṹ»ù´¡Ò²ÕýÊÇÕâÖÖÀàËÆµÄ·ÓôÇ»ù½á¹¹¡£Òì±û·Ó¿ÉÖ±½ÓÓë×ÔÓÉ»ù·´Ó¦£¬Éú³É2£¬6-¶þÒì±û»ù±½Ñõ»ùÍÅ£¬Í¬Ê±Ê¹×ÔÓÉ»ùÃð»î¡£Òì±û·ÓÖ÷ÒªµÄ¿¹Ñõ»¯»úÖÆÊÇÒÖÖÆ×ÔÓÉ»ù½éµ¼µÄÖ¬ÖʹýÑõ»¯Îï·´Ó¦¡£MurphyµÈ¡±ÈÏΪÒì±û·ÓÖ÷Òª¸ÉÈÅÁËÖ¬ÖʹýÑõ»¯µÄ¶áÇâ¹ý³Ì£¬Ðγɵķӻù½øÒ»²½ÓëÖ¬ÖʹýÑõ»¯»ù·´Ó¦ÐγÉÒ»¸ö¸üÎȶ¨µÄÎÞÌñÐԵIJúÎÖжÏÁËÖ¬ÖʹýÑõ»¯µÄÁ´Ê½·´Ó¦¡£Í¬Ê±Òì±û·ÓÁ¼ºÃµÄÖ¬ÈÜÐÔʹÆä¸üÈÝÒ×»ý¾ÛÔÚϸ°ûµÄÖ¬ÖÊË«²ãĤÉÏ£¬´Ó¶øÌá¸ßϸ°û¿¹Ñõ»¯ËðÉ˵ÄÄÜÁ¦¡£ErikssonµÈʵÑé±íÃ÷£¬ÔÚ¸ßÑõ»¯·´Ó¦Ê±Òì±û·Ó¿Éͨ¹ý²¶×½×ÔÓÉ»ù¡¢ÒÖÖÆÑõ×ÔÓÉ»ù»ò¹ýÑõ»¯Ö¬ÖÊÒýÆðµÄÀë×ÓͨµÀµ°°×µÄ¿ÉÄæÐпª·Å£¬·ÀÖ¹ÏßÁ£ÌåÄÚĤͨ͸ÐÔÉý¸ß¡¢Ö×ÕͺÍÈÜѪÁ×Ö¬¶Ñ»ý£»ÔÚµÍÑõ»¯·´Ó¦Ê±Òì±û·Ó¿ÉÖ±½Ó×÷ÓÃÓÚĤ³É·Ö£¬Æä×÷ÓÃλµã¿ÉÄÜÓë»·æßËØAÏàͬ£¬´Ó¶øÒÖÖÆÏßÁ£ÌåÄÚĤͨ͸ÐÔÔö¼Ó¡¢Îȶ¨Ä¤½á¹¹£¬½øÒ»²½¼ÓÇ¿ÒìlÄڷӵĿ¹Ñõ»¯×÷Óá£ÓÐÑо¿±íÃ÷£¬Òì±û·Ó¿Éͨ¹ý½µµÍÑõ×ÔÓÉ»ùˮƽÞ׿¹Ö¬ÖʹýÑõ»¯·´Ó¦£¬¶ÔΧÊõÆÚHIRIÆð»ý¼«µÄ·ÀÖÎ×÷Óá£KokitaµÈÈÏΪ£¬Òì±û·Ó΢Á¿µÄѪ½¬Å¨¶È¾ÍÄÜ·¢»Ó¿¹Ñõ»¯×÷Óñ£»¤Ï¸°ûĤ£¬¼´Ê¹ÓëѪ½¬µ°°×½áºÏ״̬F£¬ÈÔÄÜ·¢»ÓÆä¿¹Ñõ»¯×÷Óᣵ«ÊÇ£¬Ò²ÓÐÎÄÏ×±¨µÀÒì±û·ÓµÄ¿¹Ñõ»¯×÷Óò¢²»ÓëŨ¶È³ÉÕý±È¡£Ä¿Ç°£¬ÁÙ´²Ó¦ÓõÄÒì±û·ÓÊÇÒÔ¸ÊÓÍ¡¢ÈíÁ×Ö¬¡¢´ó¶¹Ó͵ȳɷÖ×÷¸³ÐμÁ£¬ÕâÖÖÄÚÖ¬³É·ÖÔÚ´úл¹ý³ÌÖпɽµµÍÒì±û·ÓµÄ¿¹Ñõ»¯×÷Óã¬ÔÚÒ»¶¨³Ì¶ÈÉÏÏ÷ÈõÁËÆäÇå³ýÑõ×ÔÓÉ»ùµÄÄÜÁ¦£¬²¢ÇÒËæ×ÅŨ¶ÈÔö´ó£¬Æä½µµÍÒì±û·ÓµÄ¿¹Ñõ»¯×÷Óøü¼ÓÃ÷ÏÔ¡£  
2  Òì±û·ÓÓëϸ°ûÄڸƳ¬ÔØ
      ¶¯ÎïʵÑé½á¹û±íÃ÷£¬¸ÎÔà·¢ÉúȱѪÔÙ¹à×¢ËðÉËʱ£¬¸Îϸ°ûÄڸƳ¬ÔØ·¢ÉúÔ磬Ã÷ÏÔÏÈÊ®¸Îϸ°ûÄÚÆäËûÉúÎﻯѧ¸Ä±ä£¬ºÜ¿ÉÄܳÉÎªÖØÒªµÄʼ¶¯ÒòËØÖ®Ò»¡£²¢ÇÒ¸Îϸ°ûÄڸƳ¬ÔØH ¼¤»îÁ×֬øºÍµ°°×Ë®½âø£¬´Ù½øÑõ×ÔÓÉ»ù´óÁ¿Éú³É£¬Ê¹ÏßÁ£ÌåÄÚATPµÄºÏ³É¼õÉÙ£¬±»ÈÏΪÊÇÊÜËð¸Îϸ°ûËÀÍöµÄ×îºó¹²Í¬Í¨Â·¡£¸Îϸ°ûĤµ÷½Úϸ°ûÍâ¸ÆÄÚÁ÷µÄͨµÀÖ÷ÒªÓÐ3ÐÍ£ºµçѹÃſظÆÍ¨µÀ(VOC)¡¢ÊÜÌåÃſظÆÍ¨µÀ(ROC)ºÍ¸Æ¿â¿ØÖƸÆÍ¨µÀ(sac)¡£¸ÎÔàȱѪÔÙ¹àעʱ£¬¸Îϸ°ûca2 ÄÚÁ÷ÒÔROCΪÖ÷£¬ËüÊܼ¤ËغÍÉñ¾­µÝÖʵ÷½Ú£¬²»ÒªÇóĤµÄÈ¥¼«»¯£¬ÓëVOC¹ØÏµ²»Ã÷ÏÔ¡£
     ChangµÈµÄʵÑé±íÃ÷Òì±û·Ó¶ÔÓÚT-ÐÍVOC£¬ROC¡¢sac¾ùÓнÏÇ¿µÄÒÖÖÆ×÷Óá£ËùÒÔ¿¼ÂÇÒì±û·Ó¶Ô¸ÎÔàȱѪÔÙ¹àעʱ¸Æ³¬ÔØÓб£»¤×÷Óá£ÒÑÓдóÁ¿ÎÄÏ×֤ʵ£¬Òì±û·Ó¶ÔÐÄ¡¢ÄÔȱѪ¹àעʱ¸Æ³¬ÔØÓб£»¤×÷´¨£¬¶Ô¸ÎÔàȱѪȽ¹àעʱ¸Æ³¬Ôصı£»¤È·ÇлúÖÆ»¹ÓдýÓÚ½øÒ»²½Ñо¿¡£
3  Òì±û·ÓÓëϸ°ûÒò×Ó
      Ñо¿±íÃ÷£¬¶àÖÖϸ°ûÒò×Ó²ÎÓëHIRIµÄ²¡ÀíÉúÀí¹ý³Ì¡£ÕâЩ
ϸ°ûÒò×Ó¼´¿Éµ¥¸öÐÎʽҲ¿Éͨ¹ý±Ë´ËÎÊÍøÂç×´µÄЭͬ×÷ÓÃÐÎʽ¶øÒýÆð¸ÎÔàËðÉË¡£Ö×Áö»µËÀÒò×Ó-¦Á(tunmor necrosis factor-¦Á£¬TNF-¦Á)¼°°×ϸ°û½éËØl(interleukin-1£¬IL-1)ÊÇĿǰÑо¿×î»îÔ¾µÄÁ½¸öϸ°ûÒò×Ó¡£TNF-¦Á²»½ö¿ÉÖ±½Óµ¼Ö¸Îñ¼ÄÚÆ¤Ï¸°ûÖ×ÕÍ£¬ÏòÇÒ»¹¿Éͨ¹ýÖÐÐÔÁ£Ï¸°ûºÍÄÚÆ¤Ï¸°û¼äµÄÏ໥×÷Óöøµ¼Ö¸ÎÔà΢ѭ»·Õϰ­¡£´ËÍ⣬ TNFÉпɼ¤»î𤸽¶¡¸Îñ¼ÄÚµÄÖÐÐÔÁ£Ï¸°ûÊÍ·ÅÑõ×ÔÓÉ»ù¶øÔì³É¸ÎÔàËðÉË¡£Ñо¿±íÃ÷£¬IL-1²»½öÄÜ´ÙʹKC²úÉúTNF¡£»¹ÄÜÓëTNFÒ»¿ÚЭͬ×÷ÓÃÓÚÄÚÆ¤Ï¸°û£¬ÓÕµ¼ÆäºÏ³ÉÄýѪø¼°ÏËάµ°°×ø£¬´Ó¶øÆÆ»µÄÚÆ¤Ï¸°ûµÄ¹Ç
¼Ü×÷ÓÃ. ¡£¶øYoshidomeµÈÑо¿È´·¢ÏÖIL-10ÄÜÒÖÖÆTNF-¦ÁµÄmRNA±í´ï¼°¼¤»îϸ°û¼ä𤸽µÄ·Ö×Ó£¬´Ó¶ø¼õÇá¸ÎÔàµÄȱѪÔÙ¹à×¢ËðÉË¡£
    ´óÁ¿Ñо¿Ö¤Ã÷Òì±û·Óî®Ó°Ïìϸ°ûÒò×ӵIJúÉú£®ÔÚÄÚ¶¾Ëش̼¤µÄÈËѪÅàÑøÖУ¬Òì±û·ÓÔÚµÍŨ¶Èʱ±ãÓнÏÇ¿µÄÒÖÖÆTNF-¦ÁµÄ×÷Óá£ÊóÄÚ¶¾ËØÑªÖ¢Ä£ÐÍÖУ¬Ò»´Î¾²Âö×¢ÉäÒì±û·Ó10mg£¯kg²¢ÒÔ10mg£¯(kg¡¤h)µÄËÙ¶Èά³Ö£¬ÄÜÏÔÖø¼õÇáIL-6¡¢TNFµÄ·´Ó¦¡£¶¯ÎïʵÑéÖ¤Ã÷£¬Òì±û·Ó¿ÉÇá΢Ôö¼ÓlL-4µÄÊÍ·Å£¬Ìá¸ßIL-10º¬Á¿£¬¼õÇáÄÚ¶¾Ëص;ÐÔ·´Ó¦£¬¾²Âöά³Ö¿É´Ù½ø¿¹Ñ×ÐÔϸ°ûÒò×ӵIJúÉú¡£¶øÎºÏþ½àµÈÔÚÑо¿Öз¢ÏÖ£¬ÔÚ48h³ÖÐøÊä×¢ºó£¬Òì±û·Ó¿ÉÏÔÖøÉý¸ßIL-1¡¢IL-6¡¢TNF-¦ÁµÄŨ¶È¡£
4  Òì±û·ÓÓëϸ°ûµòÍöºÍÏßÁ£Ìå½á¹¹
      ¸ÎȱѪÔÙ¹à×¢ÔçÆÚ¸ÎÔàϸ°ûËÀÍöÖ÷Òª·¢ÉúÔÚ¸Îñ¼ÄÚÆ¤Ï¸°û£¬ÇÒÒÔϸ°ûµòÍöΪÖ÷¡£HIRIºóϸ°ûµòÍöÊÇÒ»¸ö¶àÒòË÷¡¢¶à»·½Ú¡¢¶à;¾¶µÄ¸´ÔÓ¹ý³Ì£¬¶øÕâÆäÖÐÑõ×ÔÓÉ»ùµÄ±¬·¢ÐÔÐγÉÊǹؼüÒòËØ¡£ÔÚÏßÁ£ÌåÑõ»¯ËðÉ˹ý³ÌÖУ®Ä¤Í¨Í¸ÐԸıä(MPT)ÊÇϸ°ûËÀÍöÕ¢ÃÅ£¬Ò²ÊÇȱѪÔÙ¹à×¢ºóϸ°ûµòÍöµÄ¹Ø¼ü»úÖÆ¡£Ñо¿Ö¤Êµ£¬Ñõ»¯Ó¦¼¤¿Éͨ¹ý¶ÔÏÙÜÕ×ªÒÆÃ¸ÛÏ»ùµÄÐÞÊε¼Ö¸ÆÃô¸ÐÐÔMPTµÄÔö¼Ó £¬Òì±û·Ó¿ÉÒÖÖÆÀëÌåÊó¸ÎÏßÁ£ÌåµÄÖ¬ÖʹýÑõ»¯·´Ó¦¸Ô´Ë£¬Òì±û·ÓÇå³ýÔÙ¹àעʱ²úÉúµÄÑõ×ÔÓÉ»ù£¬½ø¶øÒÖÖÆÏßÁ£ÌåÖ¬ÖʹýÑõ»¯×÷Óã¬Õâ¿ÉÄÜÊÇÔÚÏßÁ£ÌåˮƽµÄ¿¹µòÍö»úÖÆ¡£ÒÑÓÐÑо¿Ö¤Êµ£¬Òì±û·Ó¿É¼õÉÙHIRIºó¸Îϸ°ûµòÍöºÍ»µËÀ¡£µ«ÊÇÒì±û·Ó×÷Ϊ·ÓÀ࿹Ñõ»¯¼Á£¬ÔںܸßŨ¶È(>500¦Ìmol£¯L)»áÒýÆðÏßÁ£ÌåĤ½âñîÁªºÍÖ×ÕÍ£¬¸ÎËðº¦ÒòËØÔö¼Ó¡£
    ϸ°ûµòÍöµÄµ÷¿ØÊÜÐí¶àÒòËØÓ°Ï죬ÆäÖÐp53ºÍBcl-2»ùÒòÆð×ÅÖØÒªµÄ×÷Óã¬p53ÊÇϸ°ûµòÍöµÄ´Ù½øÕߣ¬¶øBc1-2ÊÇϸ°ûµòÍöµÄÒÖÖÆÕß¡£ÓÐÑо¿·¢ÏÖÒì±û·ÓÄܽµµÍD53µ°°×ÔÚ¹£ËÀÐļ¡Öеıí´ïˮƽºÍÔö¼ÓBcl-2µ°°×µÄ±í´ïˮƽ£¬´Ó¶ø¼õÉÙȱѪÔÙ¹à×¢Ðļ¡Ï¸°ûµòÍöµÄÊýÈÕ¡£µ«ÔÚ¸ÎÔàÖÐÒì±û·Ó¶Ôp53ºÍBc1-2»ùÒòµÄµ÷¿Ø»úÖÆÓдýÓÚ½øÒ»²½Ñо¿¡£
5  Ð¡  ½á
×ÜÖ®£¬HIRI²¢·ÇÊǵ¥Ò»µÄ²¡ÀíÉúÀí¹ý³Ì£¬¶øÊǰüº¬×Ÿ´ÔÓµÄÉú»¯¼¶Áª·´Ó¦¹ý³Ì¡£Òì±û·Ó·¢»ÓÆä±£»¤×÷ÓÃÒ²²¢·Çµ¥Ò»µÄ×÷ÓÃÓÚÉÏÊöµÄijһ»·½Ú£¬¶øÊǶàλµã¡¢¶à;¾¶¡¢½»»¥×÷ÓõĽá¹û¡£Í¬Ê±£¬Òì±û·Ó±£»¤»úÖÆÉÐδÍêÈ«Ã÷ÁË£¬»¹ÓдýÓÚ½øÒ»²½Ñо¿¡£
²Î  ¿¼  ÎÄ  Ï×
[1]  °²ÊÀÖ¥.Òì±û·ÓÓë¸ÎÔàȱѪÔÙ¹à×¢ËðÉ˵ÄÑо¿½øÕ¹.[J]ҽѧ×Û  
     2006,2(l2):4.
[2]  Áõ±£½­,ÕÔ½¨Á¦,º«³å·¼.Òì±û·Ó¿¹Ðļ¡Ï¸°ûȱÑõËðÉË×÷ÓõÄÑо¿.ÖлªÂé×í   
     Ñ§ÔÓÖ¾,2001,7(21):7
[3]  ²ÜÔÆ·É£¬Ñ¦½Ü±ó£¬ÓáÕý·æ£®ÒìÄÚ·Ó¶Ôºìϸ°û×ÔÓÉ»ùËðÉ˵ı£»¤×÷ÓÃ[J]£®ÁÙ
     ´²Âé×íѧÔÓÖ¾£¬2000£¬16(2)£º90-92.
[4]  ÎºÏþ½à£¬Áõ¼ÊÑÙ£®Íâ¿ÆÎ£ÖØ»¼Õß³ÖÐøÊä×¢Òì±û·Ó¶ÔIL-1£¬IL-6£¬TNF-¦ÁµÄÓ°
     Ïì[J]£®Ò½Ñ§ÁÙ´²Ñо¿£¬2003£¬20(6)£º492-495
[5]  ÁÖȺ£¬À×Á¢»ª£®´óÊó¸ÎȱѪ£¯ÔÙ¹à×¢ºó¸Îϸ°ûµòÍöµÄÆÀ¼Û¼°Òì±û·Ó¶Ôϸ°û
     µòÍöµÄÓ°Ïì[J]£®ÖлªÂé×íѧÔÓÖ¾£¬2003£¬23(8)£º592-595£®
[6]  Murphy PG,Davies MJ£¬Columb MO£¬et al£¬Effect of propofol and thio-
     pentone on free vadical mediated oxidative stree of the
     erythrocy[J],Br J Anoesth,1996,76(4):536-540
[7]  Efiksson O£¬Pollesello P£¬Saris NE£®Inhibition of lipid peroxida-      
     tion in isolated rat livermitochndria by the general anaesthetic
     propofol[J],Biochem pharmacol,1992,44(2):391-393.
[8]  Kokita N,Hara N£®Propofol attenvates rat heart peroxide¡ªinduced
     me-chhanical and metabolic derangements in the isolated rat hea-         
     rt[J].Anesthsiology,1996,84(1):117-127.     
[9]  Taniguchi T£¬Yamamoto K£¬Ohnmto N£¬et a1£®Efects of pmpofol on he-   
     modynamic and inflammatory responses to endotoxemia in rats[J].
     Crit Care Med£¬2000£¬28(4)£º1101£®1106£®
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hb1983

ľ³æ (ÖøÃûдÊÖ)

0.5

ºÃ¶«¶«Ö§³Ö
2Â¥2006-05-26 16:29:52
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

×·Òä

ľ³æ (ÕýʽдÊÖ)

0.5

Ö§³Ö¼ÌÐøÅ¬Á¦°É
»¶Ó­´ó¼Ò¹âÁÙÎÒµÄÖ÷Ò³£¡www.zhuiyi51.51.com
3Â¥2006-06-02 14:42:59
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ gcr791030 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¿¼Ñе÷¼Á +7 15615482637 2026-04-04 7/350 2026-04-06 22:56 by chenzhimin
[¿¼ÑÐ] 288Çóµ÷¼Á +9 ûÓдð°¸_ 2026-04-05 9/450 2026-04-06 22:45 by chenzhimin
[¿¼ÑÐ] Ò»Ö¾Ô¸¹ú¿Æ´óÐŹ¤Ëù,Ó¢¶þÊý¶þ408×Ü·Ö293·ÖÇóµ÷¼Á +3 ilcyuan 2026-04-02 4/200 2026-04-06 16:35 by likeihood
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-05 13/650 2026-04-06 15:38 by lin-da
[¿¼ÑÐ] ÇóÖú071001µ÷¼Á£¡£¡£¡ +4 »ÆÊØËÉ 2026-04-05 5/250 2026-04-06 10:55 by 1028907439
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á +12 lyz0427 2026-04-03 12/600 2026-04-06 06:37 by houyaoxu
[¿¼ÑÐ] ¹¤¿Æ08-»úеר˶-Çóµ÷¼Á +3 À×Å··ÉÌß 2026-04-02 3/150 2026-04-05 18:49 by À¶ÔÆË¼Óê
[¿¼ÑÐ] һ־Ըͬ¼Ã´óѧ323·Ö£¨080500£©Çóµ÷¼Á +8 yikeniu 2026-04-01 8/400 2026-04-05 18:15 by cql1109
[¿¼ÑÐ] 292·Ö£¬²ÄÁÏÓ뻯¹¤£¬ÉêÇëµ÷¼Á +22 ³ÌÇçÖ® 2026-04-01 26/1300 2026-04-04 22:03 by hemengdong
[¿¼ÑÐ] »·¾³285·Ö£¬¹ýÁù¼¶£¬Çóµ÷¼Á +10 xhr12 2026-04-02 10/500 2026-04-04 21:53 by bn53987
[¿¼ÑÐ] 309Çóµ÷¼Á +6 ÁõÁõÁõ1231 2026-04-02 7/350 2026-04-04 13:41 by liucky
[¿¼ÑÐ] Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-04 3/150 2026-04-04 12:19 by Éá¶øºóµÃ
[¿¼ÑÐ] 357Çóµ÷¼Á +13 1050389037 2026-04-03 13/650 2026-04-03 22:27 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 274Çóµ÷¼Á +9 ˳Àí³ÉÕÅ 2026-04-03 10/500 2026-04-03 15:10 by °¡¿¡£¡
[¿¼ÑÐ] ÍÁľˮÀû328·ÖÇóµ÷¼Á +6 ¼²·çÖª¾¢²Ý666 2026-04-02 6/300 2026-04-03 11:38 by znian
[¿¼ÑÐ] ÄÜÔ´¶¯Á¦ µ÷¼Á +3 ²»ÆÆ²»Á¢0 2026-04-02 3/150 2026-04-02 12:46 by ffffjjjj
[¿¼ÑÐ] 354Çóµ÷¼Á +4 lxb598 2026-03-31 5/250 2026-04-02 09:55 by Jaylen.
[¿¼ÑÐ] 379Çóµ÷¼Á +3 ?¿à¹Ï²»¿à 2026-04-01 3/150 2026-04-01 20:09 by ÄºÔÆÇ庮
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +7 Ë«ÂíβƦÀϰå2 2026-03-31 7/350 2026-03-31 19:49 by Dyhoer
[¿¼ÑÐ] Ó¢Ò»ÊýÒ»×Ü·Ö334Çóµ÷¼Á +4 ³ÂÑôÀ¤ 2026-03-31 4/200 2026-03-31 14:22 by ¼Çʱ¾2026
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û